Hormone Therapy, Breast Cancer Survivors & High Risk Women with Dr. Lisa Larkin
- 20 hours ago
- 2 min read
Explore the complexities of midlife women’s health, focusing on menopause management, cancer survivorship, and the importance of integrated, personalized care. Lisa Larkin MD FACP MSCP, a seasoned internist specializing in women’s health, sits down with Lisa Malia Norman, MSM for The Clear Pathways Program to share her insights on systemic barriers, updates in treatment options, and how to advocate for yourself in a fragmented healthcare system.
Dr. Lisa Larkin shares her extensive expertise in women's health, menopause, and breast cancer, emphasizing the importance of integrated care, risk assessment, and education to improve health outcomes for women in midlife and beyond.
Hormone Therapy, Breast Cancer Survivors & High Risk Women with Dr. Lisa Larkin
Share with someone below who needs to hear this and help us reach more women with this important information.
Clear Voices Of Hope, powered by For The Love Of Cups tune into the full series for more incredible interviews with leading experts and advocates.
FOLLOW:
Dr. Lisa Larkin on LinkedIn: https://www.linkedin.com/in/lisalarkinmd/
Menopause Society - https://www.menopause.org/
Her Medicine - https://hermedicine.org/
OncoMenopause - https://oncomenopause.org/
The Clear Pathways Program: The program's mission is to remove the barriers women with dense breast tissue face in getting timely, appropriate follow-up care — creating a more standardized, seamless experience for patients from the moment they learn their breast density through supplemental screening and diagnosis.
RESOURCES:
The Clear Pathways Prorgram Resources: https://www.breastdensitysummit.org/clear-pathways-resources-research
The Clear Pathways Program: https://www.breastdensitysummit.org/
Donate: https://givebutter.com/uhbcL0
Join The Clear Pathways Advisory Board: https://www.breastdensitysummit.org/advisory-board-registration
FOLLOW LISA MALIA:
Lisa Malia on LinkedIn: https://www.linkedin.com/in/lisamalianorman/
KEY TOPICS:
The evolution of menopause treatment and research
The importance of integrated care across specialties
Risk assessment and personalized medicine in breast cancer and menopause
The impact of social media on women's health education
Strategies to improve healthcare delivery for midlife women
The role of genetics and radiomics in risk prediction
Addressing healthcare fragmentation and improving clinician education
The significance of survivorship care and quality of life
About Dr. Lisa Larkin:
Dr. Lisa Larkin is a board-certified internist and women's health expert with over 34 years of experience in clinical practice (in both academics and private practice), women’s health education, advocacy and innovation. She is Founder and CEO of Ms.Medicine, a national MSO working to raise the standard of care for women by creating a network of women’s health primary care clinicians practicing in a concierge practice model and Founder and Executive Director of HERmedicine a non-profit committed to advancing women’s health through consumer and physician/clinician education and the OncoMenopause Consortium a multidisciplinary organization advancing menopause care of cancer survivors. She is also President and CEO of Concierge Medicine of Cincinnati, a multispecialty concierge internal medicine and women’s health practice with 3 locations and 12 female physicians/clinicians where she continues to practice. She served on the Board of Trustees of The Menopause Society from 2018 through 2025 serving as iScientific Program Chair (2023) and President (2024).
Dr. Larkin’s expertise includes menopause, sexual health, breast cancer prevention, genetics and survivorship. She is a well-published author, speaker, consultant, and media resource on these topics. She is a graduate of Yale University School of Medicine and the University of Chicago.
Comments